Replies to Post #1126 onBristol Myers Squibb (BMY) | InvestorsHub

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

News Focus

News Focus

Replies to post #1126 on Bristol Myers Squibb (BMY)

Replies to #1126 on Bristol Myers Squibb (BMY)

02/02/23 9:06 AM

#1127 RE: DewDiligence #1126

BMY 4Q22 CC slides:

https://s21.q4cdn.com/104148044/files/doc_presentations/2022/BMY-Q4-2022-Results-Presentation-with-Appendix.pdf

04/27/23 7:56 AM

#1143 RE: DewDiligence #1126

BMY 1Q23 results…

PR:
https://news.bms.com/news/corporate-financial/2023/Bristol-Myers-Squibb-Reports-First-Quarter-Financial-Results-for-2023/default.aspx

CC slides:
https://s21.q4cdn.com/104148044/files/doc_presentations/2023/BMY-2023-Q1-Results-Presentation-Appendix.pdf

2023 non-GAAP EPS guidance remains $7.95-8.25, +4% YoY at the midpoint of the range.